Ginsenoside Rg3 Sensitizes Nasopharyngeal Carcinoma Cells to Radiation by Suppressing Epithelial Mesenchymal Transition-Reference-Cited by-同舟云学术

Ginsenoside Rg3 Sensitizes Nasopharyngeal Carcinoma Cells to Radiation by Suppressing Epithelial Mesenchymal Transition

Published:2023-03-27 Issue:5 Volume:199 Page:
ISSN:0033-7587
Container-title:Radiation Research
language:
Short-container-title:Radiation Research

Author:

Hu Guangyuan¹,Luo Na¹,Guo Qiuyun¹,Wang Dingkun²,Peng Ping¹,Liu Dongbo¹,Liu Shunfang¹,Zhang Linli¹,Long Guoxian¹,Sun Wei¹

Affiliation:

1. Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan 430030, China

2. Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan 430030, China

Publisher

Radiation Research Society

Subject

Radiology, Nuclear Medicine and imaging,Radiation,Biophysics

Link

https://meridian.allenpress.com/radiation-research/article-pdf/doi/10.1667/RADE-22-00183.1/3201441/10.1667_rade-22-00183.1.pdf

Reference43 articles.

1. S Lamouille, J Xu, R Derynck, "Nat Rev Mol Cell Biol." 15, "Molecular mechanisms of epithelial-mesenchymal transition." 178 (2014)

2. KCW Wong, EP Hui, KW Lo, et al. "Nat Rev Clin Oncol." 18, "Nasopharyngeal carcinoma: an evolving paradigm." 679 (2021)

3. AW Lee, BB Ma, WT Ng, et al. "J Clin Oncol." 33, "Management of nasopharyngeal carcinoma: current practice and future perspective." 3356 (2015)

4. PJ Deschavanne and B Fertil "Int J Radiat Oncol Biol Phys." 34, "A review of human cell radiosensitivity in vitro." 251 (1996)

5. YM Tian, MZ Liu, L Zeng, et al. "Head Neck." 41, "Long-term outcome and pattern of failure for patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy." 1246 (2019)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenosides in cancer: Proliferation, metastasis, and drug resistance;Biomedicine & Pharmacotherapy;2024-08

2. Integrating Chinese medicine into mainstream cancer therapies: a promising future;Frontiers in Oncology;2024-06-18

3. Targeting the DNA damage response (DDR) of cancer cells with natural compounds derived from Panax ginseng and other plants;Journal of Ginseng Research;2024-04

4. Unveiling the experimental proof of the anticancer potential of ginsenoside Rg3 (Review);Oncology Letters;2024-02-28